ASX dividend stocks surge as brokers hike FY27 targets

The late-2026 emphasis on ASX dividend names did not emerge in a vacuum; it sat on a retirement-income framework shaped nearly two decades earlier. In 2007, the Australian Government abolished tax on investment earnings in the retirement phase of complying superannuation pensions, a change that increased the relevance of dividends and franking credits for retirement income planning and helps explain why, by July to October 2026, renewed broker buy calls and FY27 income discussions resonated so strongly with investors focused on dependable cash flow as well as upside.

That backdrop was visible in the way late-2026 market commentary framed demand: Revisiting The Top 10 High-Yield Stocks Of 2026 said that, with markets remaining volatile and retirement becoming increasingly expensive, investors were searching for dependable investments capable of producing meaningful income. It also set out a distinctly forward-looking test for dividend ideas — asking whether the distribution was still sustainable and whether the investment remained attractive today — underscoring how the period’s buy-rating renewals and income quantification were being read through an FY27 retirement-income lens.

The broker buy-rating wave was not just about maintaining optimism; it was about lifting forward assumptions as earnings drivers improved. The Motley Fool Australia reported that “Bell Potter raised its outlook for Develop Global… because copper and zinc prices are stronger than expected” and expects a “first full quarter operating at commercial production levels,” plus “Higher-grade ore,” with those catalysts expected to “support stronger earnings,” while “Netwealth shares… attracted a buy recommendation from Bell Potter this week,” backed by the “agreement with Morgan Stanley Wealth” and further wins expected to unfold over the next year.

That pattern broadened across the ASX 200 as brokers renewed or reiterated buy ratings across multiple names while also adjusting 12-month price targets, showing an upward revision and renewal pattern in the broker buy-rating wave. UBS “renewed its buy rating” on National Australia Bank with a “12-month price target of $50,” while Bell Potter “reaffirmed its buy rating” on Mineral Resources, and each call was framed through upside, with NAB’s target “suggests a potential 20% upside ahead” and Mineral Resources “suggesting almost 30% upside ahead”; even where caution remained, such as Domino’s after an “FY26 earnings update and balance sheet review” with preliminary underlying “net profit after tax (NPAT)” guidance intact, the buy case stayed anchored to earnings resilience. By August, brokers were explicitly tying fresh buy calls to revised growth forecasts, reinforcing why dividend-paying shares with credible expansion stories were attracting demand. On 10 Aug. 2026, “the team at Morgans placed fresh buy recommendations on both ASX 200 companies”; for ResMed, Q4 results “prompted fresh guidance from the broker,” with underlying trends supporting “c5-7% revenue and c12-14% EPS growth,” and Morgans reaffirmed buy ratings on two ASX 200 stocks while tying the calls to updated earnings outlooks and broker forecast changes, showing how reaffirmed ratings and target changes were being driven by forward earnings momentum rather than backward-looking valuation alone.

A parallel strand of ASX coverage stopped talking about dividends in abstract yield terms and instead translated them into retiree-style income targets. The Motley Fool Australia asked, “How many AFIC shares would it take to match the Age Pension?” and used the “maximum Age Pension for a single person… approximately $31,200 annually” to calculate “117,736 Australian Foundation Investment Co” shares, with the share requirement explicitly based on “the expected FY26 payout excluding the franking credits” versus “including the franking credits,” grounding the exercise in a forward payout period rather than a vague rule of thumb.

The same framing appeared in smaller, more practical goals, turning dividend stocks into a budgeting tool for 2027. The Motley Fool Australia said, “Considering we've just started the 2027 financial year… To earn $1,000 of dividend income, someone would need to own 1,220 Coles shares. Or, if we include the franking credits, it would take 854 Coles shares,” then priced the plan as well: “At the time of writing, those two goals would cost approximately either $28,500 or $20,000,” using a CommSec estimate that the annual dividend could rise in FY27 to 82 cents per share.

What is driving the buy case is not a new theory but a familiar equation: earnings momentum, dividend support, and a sector tailwind strong enough to make those payouts believable. The Motley Fool Australia’s Fortescue example makes that explicit, saying the miner has “operating leverage when the commodity price rises” because “Production costs don't typically change much month to month,” so “a rise in the iron ore price can boost revenue, and most of that can flow straight into the net profit,” even as FY27 dividends remain tied to iron ore forecasts rather than promise alone.

That same formula also explains why optimism is selective rather than indiscriminate: for FY26, Fortescue “grew revenue by 9% to US$17 billion,” “underlying EBITDA grew by 9% to US$5.6 billion,” and NPAT rose 3% to US$3.45 billion, yet EPS fell 2% and the full-year dividend slipped 2%, with CommSec projecting FY27 dividends of 85.9 cents a share. In aged care, by contrast, The Motley Fool Australia pointed to Regis Healthcare’s EBITDA rising 10% to $138 million and net profit 4% to $55.6 million, alongside a projected 15.1-cent FY27 dividend, a FY29 payout of 19.2 cents, and the long-term demand tailwind of an ageing population needing 10,000 new beds a year.